Concepedia

Ariel Grajales‐Cruz

AG

Statistics

Publications

8

Citations

233

H-Index

8

Active since

2017

Affiliations

Moffitt Cancer Center(Current)

Stanford University

Levine Cancer Institute

Fred Hutch Cancer Center

Cleveland Clinic

Ariel Grajales‐Cruz is an author at Moffitt Cancer Center specializing in oncology, medicine, and multiple myeloma therapy.

ORCID

Publications per year

2017–2025

8

Publications

8

Early cytopenias and infections after standard of care idecabtagene vicleucel in relapsed or refractory multiple myeloma

Jennifer M. Logue, Lauren C. Peres, Hamza Hashmi et al. · Blood Advances · 2022 · 99 citations · Full text

, , +14

Tumor burden quantified by soluble B-cell maturation antigen and metabolic tumor volume determines myeloma CAR-T outcomes

Ciara L. Freeman, Jerald Noble, Meghan Menges et al. · Blood · 2024 · 33 citations

, , +17

Sequential targeting in multiple myeloma: talquetamab, a GPRC5D bispecific antibody, as a bridge to BCMA CAR-T therapy

Binod Dhakal, Othman Salim Akhtar, David Fandrei et al. · Blood · 2025 · 24 citations

, , +17

Talquetamab Bridging: Paving the Way to B-Cell Maturation Antigen (BCMA) CAR-T Cell Therapy in Relapsed/Refractory Multiple Myeloma (RRMM)

Binod Dhakal, Othman Salim Akhtar, Andrew J. Cowan et al. · Blood · 2024 · 17 citations

, , +17

Primary Adrenal Angiosarcoma: A Rare and Potentially Misdiagnosed Tumor

Ariel Grajales‐Cruz, Francis Baco-Viera, E Rivé-Mora et al. · Cancer Control · 2017 · 16 citations · Full text

, , +14

1–5 of 8